线粒体功能障碍与代谢重编程在脓毒症相关急性肾损伤中作用的研究进展
本文综述线粒体功能障碍与代谢重编程在脓毒症相关急性肾损伤(SA-AKI)发病中的作用及相互作用。线粒体损伤不仅破坏能量供应,还诱导氧化应激、炎症反应及多种细胞死亡形式,促进SA-AKI发生发展。代谢重编程改变细胞营养利用模式并影响细胞死亡决策。两者形成复杂交互网络,共同推动SA-AKI进展。文章旨在为靶向调控线粒体功能恢复或代谢重编程关键通路的临床干预提供新思路。
要点
- SA-AKI是脓毒症常见并发症和急性肾损伤主要原因,延长住院、增加死亡,并可能进展为慢性肾脏病。
- 线粒体功能障碍通过破坏能量供应、诱导氧化应激、炎症反应及多种细胞死亡形式参与SA-AKI。
- 代谢重编程改变细胞营养利用模式并影响细胞死亡决策,是SA-AKI另一关键机制。
- 线粒体功能障碍与代谢重编程并非独立,而是形成复杂交互网络共同驱动SA-AKI。
- 靶向调控线粒体功能恢复或代谢重编程关键通路,可能为SA-AKI临床干预提供新思路。
适用人群与场景
- 脓毒症患者,尤其关注发生急性肾损伤(SA-AKI)者;场景涉及急诊/ICU及住院全程。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及具体药物剂量或处置流程,仅提出靶向调控线粒体功能恢复或代谢重编程关键通路的新思路。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 综述汇总最新研究进展:线粒体功能障碍与代谢重编程在SA-AKI发病中起关键作用,二者形成交互网络驱动疾病发展。
证据类型、等级与局限
- 综述(review),证据等级与推荐强度原文未提及;局限为机制性综述,未提供临床干预剂量或前瞻性验证数据。
对床旁实践的改变
- 当前不改变具体床旁处置;提示未来可能通过调控线粒体功能或代谢重编程关键通路进行临床干预,但尚需前瞻性验证,适用与不适用人群原文未明确。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Sepsis-associated acute kidney injury (SA-AKI) is one of the most prevalent complications of sepsis and a leading cause of acute kidney injury. It not only prolongs hospitalization and increases mortality but may also progress to chronic kidney disease, severely compromising patients' quality of life. Recent studies have highlighted the critical roles of mitochondrial dysfunction and metabolic reprogramming in the pathogenesis of SA-AKI. Mitochondria are the central hub of cellular energy metabolism; their impairment not only disrupts energy supply but also induces oxidative stress, inflammatory responses, and various forms of cell death, collectively contributing to the initiation and progression of SA-AKI. Metabolic reprogramming, another key mechanism underlying SA-AKI, alters cellular nutrient utilization patterns and influences cell death decisions. These two pathogenic mechanisms are not independent but form an intricate interactive network that drives the development of SA-AKI. This article reviews the latest research advances on the roles of mitochondrial dysfunction and metabolic reprogramming in SA-AKI and discusses their interactions, with the aim of providing new ideas for clinical intervention targeting the regulation of key pathways for mitochondrial function restoration or metabolic reprogramming.
参考来源
- Zhao S, Huangfu W, Zhou L, et al. [Research advances on the role of mitochondrial dysfunction and metabolic reprogramming in sepsis-associated acute kidney injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 42693977. doi:10.3760/cma.j.cn121430-20260130-00064
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。